Response to the letter to the Editor concerning our article "High adherence of patients with multiple myeloma who receive treatment with immunomodulatory drugs (IMIDS) in hematology/oncology group practices in Germany"

Support Care Cancer. 2020 Jan;28(1):3-4. doi: 10.1007/s00520-019-05126-z. Epub 2019 Nov 8.
No abstract available

Publication types

  • Letter

MeSH terms

  • Germany
  • Group Practice
  • Hematology
  • Humans
  • Immunologic Factors / therapeutic use*
  • Multiple Myeloma / drug therapy*
  • Patient Compliance / statistics & numerical data*
  • Physician-Patient Relations*

Substances

  • Immunologic Factors